PhillyPharma Archive: August, 2012

J&J admits no guilt in paying off states for Risperdal

Comment icon 0 Comments
Thursday's announcement of the $181 million settlement between Johnson & Johnson with 36 states and the District of Columbia over Risperdal... Read more

Doctors closing door on oncology drug reps, study says

Comment icon 0 Comments
Targeted cancer drugs are one of the great hopes for pharmaceutical companies, but a business survey says cancer doctors are limiting visits... Read more

J&J to pay $181 million to 36 states, District of Columbia over Risperdal

Comment icon 0 Comments
Thirty-six states and the District of Columbia will share in $181 million that Johnson & Johnson has agreed to pay to resolve allegations... Read more

Bristol-Myers Squibb hepatitis C bet has not paid off

Comment icon 0 Comments
Bristol-Myers Squibb spent $2.5 billion to acquire an experimental hepatitis C drug earlier this year, but the bet does not look good after... Read more

AstraZeneca hires Roche's Pascal Soriot to be new CEO

Comment icon 0 Comments
AstraZeneca said Tuesday morning that its new chief executive officer will be Pascal Soriot, who has been chief operating officer of Roche... Read more

FDA approves four-in-one HIV pill

Comment icon 0 Comments
The U.S. Food and Drug Administration on Monday approved a once-a-day AIDS medicine that combines four drugs in one pill and is produced by... Read more

PhillyPharma to return Aug. 28

Comment icon 0 Comments
A note to regular readers of the PhillyPharma blog. Updates to the blog will begin again on Tuesday, August 28, 2012. Until then, be well.... Read more

'Heroes of Chemistry' award to hepatitis C team from Merck

Comment icon 0 Comments
The American Chemical Society will hold its 224th national meeting in Philadelphia starting Sunday and the five-day gathering kickoffs with... Read more